» Articles » PMID: 11934228

Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes' Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2002 Apr 6
PMID 11934228
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Key factors that contribute to the aerodynamic properties of aerosol particles are found in Stokes' law. These factors may be monitored or controlled to optimize drug delivery to the lungs. Predictions of the aerodynamic behavior of therapeutic aerosols can be derived in terms of the physical implications of particle slip, shape and density. The manner in which each of these properties have been used or studied by pharmaceutical scientists to improve lung delivery of drugs is readily understood in the context of aerosol physics. Additional improvement upon current aerosol delivery of particulates may be predicted by further theoretical scrutiny.

Citing Articles

Unraveling the impact of operational parameters and environmental conditions on the quality of viable bacterial aerosols.

Thirugnanasampanthar M, Tian L, Rhem R, Libera D, Gomez M, Jackson K PNAS Nexus. 2024; 3(11):pgae473.

PMID: 39529911 PMC: 11551483. DOI: 10.1093/pnasnexus/pgae473.


Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.

Salustio P, Amaral M, Costa P J Aerosol Med Pulm Drug Deliv. 2024; 37(6):307-327.

PMID: 39120712 PMC: 11669763. DOI: 10.1089/jamp.2023.0029.


Lattice variation as a function of concentration and grain size in MgO-NiO solid solution system.

Barad C, Kimmel G, Opalinska A, Gierlotka S, Lojkowski W Heliyon. 2024; 10(10):e31275.

PMID: 38803881 PMC: 11129000. DOI: 10.1016/j.heliyon.2024.e31275.


Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.

Magi M, de Lafuente Y, Quarta E, Palena M, Ardiles P, Paez P Pharmaceutics. 2024; 16(4).

PMID: 38675098 PMC: 11054002. DOI: 10.3390/pharmaceutics16040436.


Particulate bioaerogels for respiratory drug delivery.

Li H, Makatsoris C, Forbes B J Control Release. 2024; 370:195-209.

PMID: 38641021 PMC: 11847494. DOI: 10.1016/j.jconrel.2024.04.021.


References
1.
Darquenne C, Paiva M, Prisk G . Effect of gravity on aerosol dispersion and deposition in the human lung after periods of breath holding. J Appl Physiol (1985). 2000; 89(5):1787-92. DOI: 10.1152/jappl.2000.89.5.1787. View

2.
Martonen T . Analytical model of hygroscopic particle behavior in human airways. Bull Math Biol. 1982; 44(3):425-42. DOI: 10.1007/BF02462290. View

3.
Edwards D, Ben-Jebria A, Langer R . Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol (1985). 1998; 85(2):379-85. DOI: 10.1152/jappl.1998.85.2.379. View

4.
Moss O . Shape factors for airborne particles. Am Ind Hyg Assoc J. 1971; 32(4):221-9. DOI: 10.1080/0002889718506442. View

5.
Fults K, MILLER I, Hickey A . Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols. Pharm Dev Technol. 1997; 2(1):67-79. DOI: 10.3109/10837459709022610. View